Skip to market wire
InvestLog
← Back to Research← 返回研究
6955.HKEarnings Release财报快讯Source checked来源已核对Source link原始来源August 27, 20262026/8/27by InvestLog AIInvestLog AI 整理

Shandong Boan Biotechnology Co., Ltd. (6955.HK) 2026 H1 financial resultsShandong Boan Biotechnology Co., Ltd. (6955.HK) 2026 H1 财报发布

Key Results

Shandong Boan Biotechnology Co., Ltd. reported revenue CN¥233M, net income -CN¥83M.

Profitability and Cash Flow

  • Period: 2026 H1
  • Revenue: CN¥233M; YoY: -40.8%
  • Gross profit: CN¥146M; Gross margin: 62.7%; YoY: -48.3%
  • Net income: -CN¥83M; Earnings per share: -CN¥0.13; Net margin: -35.6%

    • Official release: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026

    核心结果

    Shandong Boan Biotechnology Co., Ltd. 公布2026 H1财报：营收 CN¥233M，净利润 -CN¥83M。

    财务指标

  • 期间：2026 H1
  • 营收：CN¥233M；同比 -40.8%
  • 毛利润：CN¥146M；毛利率：62.7%；同比 -48.3%
  • 净利润：-CN¥83M；每股收益：-CN¥0.13；净利率：-35.6%
    • View 6955.HK stock details ->查看 6955.HK 个股详情 ->

    This earnings research was prepared from company results, regulatory filings, and financial statements. It is for informational purposes only and does not constitute investment advice.这篇财报研究基于公司业绩公告、监管文件和财务报表整理。内容仅供参考，不构成投资建议。